B Obermayer-Pietsch
Overview
Explore the profile of B Obermayer-Pietsch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
1349
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kanis J, Johansson H, McCloskey E, Liu E, Akesson K, Anderson F, et al.
Osteoporos Int
. 2023 Aug;
34(12):2027-2045.
PMID: 37566158
Introduction: The aim of this study was to quantify the fracture risk associated with a prior fracture on an international basis and to explore the relationship of this risk with...
2.
Vandenput L, Johansson H, McCloskey E, Liu E, Akesson K, Anderson F, et al.
Osteoporos Int
. 2022 May;
33(10):2103-2136.
PMID: 35639106
Introduction: The availability of the fracture risk assessment tool FRAX® has substantially enhanced the targeting of treatment to those at high risk of fracture with FRAX now incorporated into more...
3.
Vlot M, den Heijer M, de Jongh R, Vervloet M, Lems W, de Jonge R, et al.
Bone
. 2018 Jun;
114:215-225.
PMID: 29920402
Measurements of bone markers (BMs) in peripheral blood or urine are a pivotal part of bone research within modern clinical medicine. In recent years the use of BMs increased substantially...
4.
Schwetz V, Schnedl C, Urbanic-Purkart T, Trummer C, Dimai H, Fahrleitner-Pammer A, et al.
Osteoporos Int
. 2017 Aug;
28(12):3347-3354.
PMID: 28842727
Introduction: Observational studies have shown accelerated bone loss in ICU survivors. A reversible contributor is vitamin D deficiency. In a post hoc analysis of the VITdAL-ICU study, we evaluated the...
5.
Diez-Perez A, Naylor K, Abrahamsen B, Agnusdei D, Brandi M, Cooper C, et al.
Osteoporos Int
. 2017 Jan;
28(3):767-774.
PMID: 28093634
Introduction: Low adherence to oral bisphosphonates is a common problem that jeopardizes the efficacy of treatment of osteoporosis. No clear screening strategy for the assessment of compliance is widely accepted...
6.
Munzker J, Lindheim L, Adaway J, Trummer C, Lerchbaum E, Pieber T, et al.
Clin Endocrinol (Oxf)
. 2017 Jan;
86(4):567-575.
PMID: 28039871
Background: Polycystic ovary syndrome (PCOS) is characterized by a combination of hormonal and metabolic disturbances, such as insulin resistance, glucose intolerance, anovulation and hyperandrogenism. Clinical phenotypes of PCOS show different...
7.
Ulbing M, Kirsch A, Leber B, Lemesch S, Munzker J, Schweighofer N, et al.
Bone
. 2016 Nov;
95:115-123.
PMID: 27866993
Chronic kidney disease (CKD) is associated with a multifactorial dysregulation of bone and vascular calcification and closely linked to increased cardiovascular mortality and concomitant bone disease. We aimed to investigate...
8.
Mayer-Pickel K, Kolovetsiou-Kreiner V, Mortl M, Schlembach D, Eberhard K, Obermayer-Pietsch B, et al.
J Reprod Immunol
. 2016 Jun;
116:86-92.
PMID: 27267037
No abstract available.
9.
Obermayer-Pietsch B, Schwetz V
Z Rheumatol
. 2016 May;
75(5):451-8.
PMID: 27146404
Laboratory analyses of biochemical markers for bone and mineral metabolism can play a key role in the assessment of patients with osteoporosis. They may help to assess bone turnover in...
10.
Schweighofer N, Aigelsreiter A, Trummer O, Graf-Rechberger M, Hacker N, Kniepeiss D, et al.
Bone
. 2016 Apr;
88:31-38.
PMID: 27108945
Calcification is not only physiologically present in bone but is a main pathophysiological process in vasculature, favouring cardiovascular diseases. Our aim was to investigate changes in the expression of calcification...